Trial intelligence / Profile preview

Intravenous lidocaine infusion for pain after femoral neck fracture surgery

IRCT20170516033992N12Phase 3Completed

Sponsor
Urmia University of Medical Sciences
Start
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in acute postoperative pain comparing Lidocaine infusion with Placebo (2 arms). Primary endpoint: Pain intensity. Started Dec 2022; status: completed.

02

Drugs

lidocaine
03

Conditions

acute postoperative pain

Beyond the preview

Go deeper on IRCT20170516033992N12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170516033992N12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call